scorecardresearch
Add as a preferred source on Google
Sunday, February 15, 2026
TopicModerna

Topic: moderna

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

With aim to tackle vaccine inequity, African firm tries to replicate Moderna Covid shot

Afrigen Biologics and Vaccines is relying on the US company’s pledge that it will not enforce its patent during the pandemic.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

Covid pandemic: Philippines approves Moderna for 12-17 year olds, Delta hits Vietnam hard

ThePrint brings you some important global stories on the coronavirus pandemic.

Human trials for the first mRNA HIV vaccine will begin this week. Here’s how it will work

The Covid-19 vaccine giant will enrol humans in two-year-long HIV vaccine trials that begins this week to test for safety and immunogenicity, after promising preliminary results earlier this year.

Moderna’s mRNA vaccine safe & effective in teens, US clinical trial findings show

Among the 2,489 participants who received the mRNA-1273 vaccine, the most common adverse reactions included pain in the injection site, headache and fatigue.

India unlikely to give indemnity to foreign vaccines, may consider only if shortage persists

Modi govt is not inclined to give Moderna or any other foreign vaccine manufacturer indemnity as long as the vaccine programme's target seems achievable by current supply.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

Second mRNA vaccine shot safe for people who had allergic reactions to first shot: US study

Of the 189 patients who participated in the study, 130 received the Moderna vaccine, while 59 got the Pfizer-BioNTech vaccine. Second dose was administered to 159 subjects.

Even quarter dose of Moderna’s Covid vaccine induces robust immune response, study says

Researchers from a US institute inoculated 35 people with 25 micrograms of the Moderna vaccine and found antibodies six months after vaccination. Standard dose of vaccines is 100 micrograms.

On Camera

How Nehru defended restrictions on freedom of speech and the press

On 29 May 1951, Jawaharlal Nehru defended adding 'reasonable restrictions' to Article 19, arguing that free speech must be balanced with national security and unity.

Andhra proposes Rs 100-cr wealth fund, eyes Norway-style sovereign fund model to drive growth

Andhra Pradesh Finance Minister Payyavula Keshav presented a Rs 3.32 lakh crore budget for 2026–27 in the assembly Saturday.

Top US military commander applauds ‘India’s tactical execution’ during Op Sindoor; adds ‘there’s lessons too’

On bilateral ties, Admiral Paparo said India-US ties have an exponential effect on deterrence, because it demonstrates a unity of purpose among us to maintain the peace.

The new Great Game—Trump’s playing for time, China for leverage & India for wiggle room

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.